Overview

Study to Assess Hemodynamic Effects, Safety and Tolerability of Chimeric Natriuretic Peptide (CD-NP) in Patients With Stabilized Acute Heart Failure (AHF)

Status:
Completed

Trial end date:
2008-12-01

Target enrollment:

Participant gender:

Summary

To access the efficacy of intravenous (IV) administration of CD-NP on changes in cardiac output and wedge pressure in patients with stabilized acute heart failure

Phase:

Phase 2

Details

Lead Sponsor:

Nile Therapeutics

Collaborator:

Momentum Research, Inc.